For cancer patients, e-cigarettes not helpful for smoking cessation
the ONA take:
According to a new study published in the journal Cancer, patients with cancer who use e-cigarettes as a form of smoking cessation are equally or less likely to quit smoking compared with those who do not use e-cigarettes. Researchers from Memorial Sloan-Kettering Cancer Center in New York City, New York, sought to examine whether cancer patients using e-cigarettes affect smoking cessation due to the increased use of the device.
In the study, researchers followed 1,074 patients with cancer that smoke who were receiving care at a comprehensive cancer center and also part of a tobacco treatment program between 2012 and 2013. During that time, e-cigarette use rose from 10.6% to 38.5% of patients.
At follow-up, researchers found that the patients using e-cigarettes were equally as likely as non-users to still be smoking cigarettes. Furthermore, patients using e-cigarettes were found to be twice as likely to be regular smokers of cigarettes compared with non-users.
The American Cancer Society does not recommend for or against the the use of e-cigarettes for smoking cessation due to the lack of known and benefits and potential risks associated with long-term use.
Patients with cancer who use e-cigarettes are equally or less likely to quit smoking.
Despite the well-documented risks to health that are posed by smoking, previous research has shown that smoking habits can continue long after a cancer diagnosis has been made. The authors of the new study state that approximately two thirds of smokers diagnosed with cancer continue to do so after diagnosis.
This continuation is problematic, as smoking can cause new mutations among cancer survivors, resulting in secondary or further forms of primary cancer. Smoking can also reduce how effective cancer treatments are.
Sign Up for Free e-newsletters
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- Alternate Dosing of Ruxolitinib May Alleviate Anemia in Myelofibrosis
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- Combined Digital Screening Best for Detecting Breast Cancers
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Seeking Reliable Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Oral Hydration Effectively Reduced Risk of Nephrotoxity After Cisplatin
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- The Efficacy and Tolerance of High Pressure Oxygen Combined With Chemotherapy in Postoperative Patients With Advanced Gastric Cancer
- Hepatocellular Cancer Pain: Impact and Management Challenges
- Serum Albumin May Indicate Prognosis for Survival in Acute Myeloblastic Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|